BeneVir is a biotechnology company that focuses on developing oncolytic immunotherapies for the treatment of cancer... Read more
BeneVir is a biotechnology company that focuses on developing oncolytic immunotherapies for the treatment of cancer... Read more
News
Jun 11, 2018
GlobeNewswire
Press Release: Benevir : HC2 Completes Sale of Pansend Life Sciences Portfolio Company BeneVir Biopharm to Janssen Biotech, Inc. for Up to $1.04 Billion
May 09, 2018
PharmaTech
Benevir: J&J s Janssen to Acquire BeneVir for $1 Billion
May 09, 2018
Global University Venturing
Benevir: Benevir to benefit from $1bn acquisition
May 08, 2018
The Business Journals: Baltimore
Benevir: Md. biotech to be acquired by New Jersey pharmaceutical goliath
May 03, 2018
BioPharma-Reporter
Benevir: Janssen strengthens immunotherapy capabilities with BeneVir acquisition
May 03, 2018
RTTNews
Benevir: HC2 Holdings Inc. (HCHC) Set A New High After Janssen Buys BeneVir
May 03, 2018
BioPortfolio
Benevir: J&J pays $140m upfront for cancerbusting virus firm BeneVir
May 02, 2018
The Business Journals
Benevir: Janssen Biotech's proposed purchase of a Maryland biopharm firm could top $1B
May 02, 2018
FierceBiotechIT
Benevir: Johnson & Johnson pens $140M deal for preclinical oncolytic virus startup
May 02, 2018
MassDevice
Benevir: J&J's Janssen acquires cancer-killing virus tech
Benevir Competitors
1
2
3
4
5
6
7
8
9
10